FacebookTwitterGoogle+RedditEmail

Is Your Doctor’s Continuing Ed Funded by Drug Makers?

Raise your hand if you’ve breathed a sigh of relief seeing your doctor had a CME (Continuing Medical Education) certificate next to the medical school diploma on the wall.

Did your doctor pass  Bipolar Disorder: Individualizing Treatment to Improve Patient Outcomes, Part 2 “taught” by Trisha Suppes, MD, PhD and offered by CME Outfitters?

Suppes is a Professor in Stanford’s Department of Psychiatry and Behavioral Science and funded by Abbott, AstraZeneca; GlaxoSmithKline, Janssen, Novartis, Pfizer, Wyeth, Bristol-Myers Squibb, Eli Lilly, Shire and four more drug companies.

Maybe your doctor passed Quadrivalent HPV Vaccine May Be Effective in Women 24 to 45 Years Old — which sounds like a sales pitch for Gardasil because it is — which “studies” a Lancet article written by Nubia Munoz, MD, two Merck employees and other authors.

Sample question: “What was the main conclusion of the current study by Munoz and colleagues of HPV vaccine among women between the ages of 24 and 45 years?” (Italics CME’s) Hint: the answer is in the title.

Upon “completion on this activity” offered by CME giant Medscape, part of the WebMD monolith — still available for credit if you hurry — “participants will be able to: “Specify the currently recommended age range for the administration of the quadrivalent human papillomavirus vaccine” and “Describe the effects of the quadrivalent human papillomavirus vaccine among women between the ages of 24 and 45 years.”

Maybe your doctor passed Medscape’s Innovative Approaches to Vaccination Challenges: Overcoming Barriers for Adult Patients sponsored by — surprise! — vaccine makers Novartis, GSK and Merck and meaning sales barriers.

CMEs, continuing medical education courses, are sponsored by drug makers, “taught” by industry-funded specialists and bracketed by pop-up drugs ads which sometimes occlude the text you’re reading. (“Which of the following manic symptoms are most seriously impacting your bipolar patients’ lives?” asked a disease-baiting ad for Geodon, direct-to-consumer style, when we looked at a CME.) Yet doctors are required to sit through the canned message like a time-share presentation and answer a quiz just to keep their state licenses and sometimes insurance policies.

In fact the only good thing doctors have to say about CMEs is they are hard to fail–“second chance” questions pop up if you miss the first ones; and they are often free. Why?

CMEs are supposed to be monitored by the Accreditation Council for Continuing Medical Education (ACCME) but like Standard and Poor’s and Moody’s stock ratings funding comes from the client side so buyer beware.

Last year Bernard Carroll, MD a former chairman of psychiatry at Duke, challenged the objectivity of a CME Outfitters course called Atypical Antipsychotics in Major Depressive Disorder: When Current Treatments Are Not Enough (what are they trying to say?) funded by Seroquel maker AstraZeneca and taught by disgraced Emory University psychiatrist Charles Nemeroff, MD who lost his department chairmanship from unreported drug industry income.

Two doses of Seroquel were tested but only the results of one were “statistically significant,” writes Carroll on a blog called Health Care Renewal. “One of the junior presenters stated very clearly that there was ‘significant improvement in both response and remission with both doses’ of Seroquel. That is a falsification of the scientific record.”

In October AstraZeneca agreed to pay $520 million to settle Seroquel suits and investigations of “physicians who participated in clinical trials involving Seroquel,” presumably on which safety was established, and a JAMA article red flags Seroquel’s metabolic proclivities in which studied children gained a pound a week and more. Yet AstraZeneca still seeks FDA approval to market Seroquel to kids.

Nor did the April 2009 article about Seroquel, Maintenance Treatment For Patients With Bipolar I Disorder: Results From A North American Study Of Quetiapine In Combination With Lithium Or Divalproex in the American Journal of Psychiatry (AJP) by CME presenter Trisha Suppes fare well.

Why were two-thirds of pre-randomization patients discontinued because of “lack of therapeutic response, developing an adverse event” and being lost to follow-up, ask Debasish Basu, MD, and Kaustav Chakraborty, MD from Chandigarh, India in the October AJP? “Could it be possible that the remaining patients, who did eventually proceed to the randomization phase, represented a group favorably predisposed to the quetiapine combination?”

A second letter in the same AJP echoes the methodology questions. “Only one-third of the patients were selected for maintenance therapy, which raises the possibility of selection bias,” write Bettahalasoor S. Somashekar, MD, DPM, Ashok Kumar Jainer, MD, MRCP and Wajid Shafi, MD from Coventry, UK. “In this regard, Healy [David Healy, MD, Cardiff University professor] stated that company sponsored clinical trials invariably recruit samples of convenience, which by definition do not actually sustain extrapolation to normal clinical practice.”

Similar methodology questions are raised about the “science” behind Medscape’s Quadrivalent HPV Vaccine May Be Effective in Women 24 to 45 Years Old CME in the October 10 Lancet. Not only should your sons and daughters get the Human Papillomavirus vaccine,says Merck, so should your parents.

Why did Munoz et al exclude women “with pre-existing infections and women who do not complete the full course of the vaccine,” ask six researchers with US National Cancer Institute. Is this also a sample of convenience?

Why was “infection of 6 month duration or longer” used as an endpoint for showing a cancer benefit asks a different set of researchers, Stefanie Schenk and Jutta Halbekath from Berlin, in the same Lancet issue. Why is there no “differentiation” between infection and cancer–a big scientific leap?

Clearly the letter writers need to do their CMEs.

MARTHA ROSENBERG can be reached at: martharosenberg@sbcglobal.net

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

Weekend Edition
June 15, 2018
Friday - Sunday
Dan Kovalik
The US & Nicaragua: a Case Study in Historical Amnesia & Blindness
Jeremy Kuzmarov
Yellow Journalism and the New Cold War
Charles Pierson
The Day the US Became an Empire
Jonathan Cook
How the Corporate Media Enslave Us to a World of Illusions
Ajamu Baraka
North Korea Issue is Not De-nuclearization But De-Colonization
Andrew Levine
Midterms Coming: Antinomy Ahead
Louisa Willcox
New Information on 2017 Yellowstone Grizzly Bear Deaths Should Nix Trophy Hunting in Core Habitat
Jeffrey St. Clair
Roaming Charges: Singapore Fling
Ron Jacobs
What’s So Bad About Peace, Man?
Robert Hunziker
State of the Climate – It’s Alarming!
L. Michael Hager
Acts and Omissions: The NYT’s Flawed Coverage of the Gaza Protest
Dave Lindorff
However Tenuous and Whatever His Motives, Trump’s Summit Agreement with Kim is Praiseworthy
Robert Fantina
Palestine, the United Nations and the Right of Return
Brian Cloughley
Sabre-Rattling With Russia
Chris Wright
To Be or Not to Be? That’s the Question
David Rosen
Why Do Establishment Feminists Hate Sex Workers?
Victor Grossman
A Key Congress in Leipzig
John Eskow
“It’s All Kinderspiel!” Trump, MSNBC, and the 24/7 Horseshit Roundelay
Paul Buhle
The Russians are Coming!
Joyce Nelson
The NED’s Useful Idiots
Lindsay Koshgarian
Trump’s Giving Diplomacy a Chance. His Critics Should, Too
Louis Proyect
American Nativism: From the Chinese Exclusion Act to Trump
Stan Malinowitz
On the Elections in Colombia
Camilo Mejia
Open Letter to Amnesty International on Nicaragua From a Former Amnesty International Prisoner of Conscience
David Krieger
An Assessment of the Trump-Kim Singapore Summit
Jonah Raskin
Cannabis in California: a Report From Sacramento
Josh Hoxie
Just How Rich Are the Ultra Rich?
CJ Hopkins
Awaiting the Putin-Nazi Apocalypse
Mona Younis
We’re the Wealthiest Country on Earth, But Over 40 Percent of Us Live in or Near Poverty
Dean Baker
Not Everything Trump Says on Trade is Wrong
James Munson
Trading Places: the Other 1% and the .001% Who Won’t Save Them
Rivera Sun
Stop Crony Capitalism: Protect the Net!
Franklin Lamb
Hezbollah Claims a 20-Seat Parliamentary Majority
William Loren Katz
Oliver Law, the Lincoln Brigade’s Black Commander
Ralph Nader
The Constitution and the Lawmen are Coming for Trump—He Laughs!
Tom Clifford
Mexico ’70 Sets the Goal for World Cup 
David Swanson
What Else Canadians Should Be Sorry For — Besides Burning the White House
Andy Piascik
Jane LaTour: 50+ Years in the Labor Movement (And Still Going)
Jill Richardson
Pruitt’s Abuse of Our Environment is Far More Dangerous Than His Abuse of Taxpayer Money
Ebony Slaughter-Johnson
Pardons Aren’t Policy
Daniel Warner
To Russia With Love? In Praise of Trump the Includer
Raouf Halaby
Talking Heads A’Talking Nonsense
Julian Vigo
On the Smearing of Jordan Peterson: On Dialogue and Listening
Larry Everest
A Week of Rachel Maddow…or How I Learned to Stop Worrying and Love Ronald Reagan
David Yearsley
Hereditary: Where Things are Not What They Sound Like
FacebookTwitterGoogle+RedditEmail